CITIC Xiangya Reproductive and Genetic Hospital

CITIC Xiangya Reproductive and Genetic Hospital is a premier specialized medical institution in China dedicated to assisted reproductive technology (ART) and medical genetics. Established as a joint venture between CITIC Group and Central South University, it operates one of the largest in vitro fertilization (IVF) centers in the world by cycle volume. The hospital is a pioneer in preimplantation genetic testing (PGT) and maintains China's first human sperm bank and a major embryonic stem cell research facility. Its services encompass the full spectrum of reproductive health, from advanced infertility treatments to the prevention of hereditary diseases through genetic screening. The institution is renowned for integrating high-volume clinical practice with cutting-edge research in human development and stem cell biology.